ATLANTA, July 21, 2022 –nView Health, developer of the premier evidence-based behavioral health solution that combines gold-standard measurements on a single, modern platform, invites attendees of APA 2022, the annual meeting of the American Psychological Association (APA), to visit with nView at Booth 1121. There they can see how nView’s newest solution introduces an innovative approach to mental healthcare with digital workflows based that produce actionable data.
The intelligent workflow engine captures and shares data at every step of the behavioral healthcare process, providing insight to help providers assess and diagnose mental illness and determine the next steps to take in a patient's care based on the conditions for which the patient meets criteria. This leads to a significant result: better outcomes for patients who suffer from mental illness.
The nView solution supports every stage of the clinical process:
"At nView, we are helping practitioners, researchers, educators and applied psychologists better assess, treat, and deliver outcomes for their patients with mental illness," said nView CEO John Letter. "APA 2022 provides us with a terrific opportunity to demonstrate to attendees how our new solution helps providers get the right answers at the right time to enable the right mental health outcomes and why we believe 'healthy minds start with nView.'"
To arrange an in-person demo or meeting with an nView representative at APA 2022, please contact us.
ABOUT NVIEW HEALTH
nView Health is the premier provider of evidence-based software and supporting solutions used by research organizations and healthcare professionals around the world to help them identify, treat and monitor mental health disorders — a critical requirement for measurement-based care. nView is the exclusive licensee worldwide for a broad array of behavioral health screening solutions, structured interviews, and post-diagnosis severity measurement scales to monitor patient outcomes. To learn more, visit nview.com or follow nView Health on LinkedIn or Twitter.